FemDx Medsystems, Inc. develops single-use endoscopic devices for the diagnosis and treatment of ovarian cancer and uterine fibroids, utilizing a proprietary visualization system for enhanced biopsy procedures. The company addresses the critical need for effective diagnostic and therapeutic solutions in women's health, particularly in gynecology and related fields.
Funding
Funding not disclosed
Founders
Product
Problem
Ovarian cancer and uterine fibroids lack effective diagnostic and therapeutic solutions, leading to unmet clinical needs in women's health. Current endoscopic devices may not provide sufficient visualization for accurate biopsy procedures.
Solution
FemDx Medsystems develops single-use endoscopic devices designed for improved diagnosis and treatment of gynecological conditions, including ovarian cancer and uterine fibroids. Their technology platform enables diagnostic, therapeutic, and surgical single-use endoscopy across various applications in Gynecology, Urology, ENT, and Gastroenterology. The company's proprietary visualization system aims to enhance biopsy procedures, addressing the need for more effective tools in women's health. The devices are available for a variety of indications related to different types of endoscopes.
Target Audience
The primary target audience includes gynecologists, urologists, ENT specialists, gastroenterologists, and other medical professionals focused on women's health and requiring advanced endoscopic solutions.
Features
- Single-use design to eliminate the risk of cross-contamination.
- Proprietary visualization system for enhanced image clarity during procedures.
- Endoscopic platform adaptable for diagnostic, therapeutic, and surgical applications.
- Devices available for Gynecology, Urology, ENT, and Gastroenterology procedures.